Kuwabara, Yoshihiro http://orcid.org/0000-0003-4161-2970
Yasuno, Shinji
Kasahara, Masato
Ueshima, Kenji
Nakao, Kazuwa
Article History
Received: 4 April 2019
Accepted: 13 December 2019
First Online: 26 December 2019
Compliance with ethical standards
:
: M. Kasahara report has received research funding and Honoraria from Daiichi-Sankyo Pharmaceuticals and Fuji-Yakuhin Pharmaceuticals. None of the other authors have any conflicts of interests to disclose.
: The ASUCA trial was approved by the Ethics Committee at the Kyoto University Graduate School of Medicine (C-271) and conducted in accordance with the Declaration of Helsinki Principles and related ethical guidelines.
: Written informed consent was obtained from each subject enrolled in ASUCA trial.